Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednison Alone in Metastatic Castration Resistant Prostate Cancer
by on Thursday, June 14th, 2012 | No Comments
Condition: Prostate Cancer
Interventions: Drug: Docetaxel, Reolysin and Prednisone; Drug: Docetaxel and Prednisone
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Oncolytics Biotech
Not yet recruiting – verified June 2012